
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
The Long Run with Luke Timmerman
00:00
How Big of a Life Anger Was This for You as a Co-Founder?
A company a was acquired saljean now part of beamess for i mean, multiple billions. Ithink animod is the a, a generic, generic name, but it's a small molecule that binds with a g pc r a target. A has that agonised effect, as you mention, treatment for multipl sclerosis and now ulcerative colidus. We we went public, i think, in 20 13. And then we wan a guinea, acquired by saljean for a little over seven billion us. Well, one or two billion. You know, what's the differenceh ha ho.
Transcript
Play full episode